Not treated over follow-up | 297 (46) | 0.50 (0.13–0.88) | 0.50 (0.13–1.25) | 0.13 (0.05 to 0.21) |
Treated over follow-up | 345 (54) | 1.00 (0.50–1.50) | 1.38 (0.50–2.00) | 0.24 (0.14 to 0.33) |
Time to first treatment |
<6 Months | 122 (35) | 1.25 (0.63–1.75) | 1.25 (0.25–2.13) | 0.00 (−0.17 to 0.17) |
6–12 Months | 76 (22) | 1.00 (0.44–1.63) | 1.50 (0.50–2.00) | 0.28 (0.08 to 0.48) |
>12 Months | 147 (43) | 0.75 (0.38–1.38) | 1.38 (0.63–2.00) | 0.41 (0.28 to 0.54) |
Time receiving first treatment |
≤6 Months | 91 (26) | 1.00 (0.38–1.50) | 1.63 (0.50–2.13) | 0.35 (0.15 to 0.55) |
>6 to ≤36 Months | 123 (36) | 1.00 (0.38–1.63) | 1.38 (0.63–2.00) | 0.24 (0.10 to 0.38) |
>36 Months | 131 (38) | 0.88 (0.50–1.50) | 1.25 (0.25–1.88) | 0.16 (0.002 to 0.32) |
Time receiving any treatment over 10 years |
≤48 Months | 88 (26) | 0.88 (0.25–1.50) | 0.88 (0.06–1.63) | 0.06 (−0.12 to 0.25) |
>48 to ≤96 Months | 57 (17) | 0.88 (0.38–1.63) | 1.50 (0.63–2.00) | 0.38 (0.13 to 0.63) |
>96 Months | 200 (58) | 1.00 (0.50–1.56) | 1.50 (0.63–2.13) | 0.27 (0.15 to 0.39) |